MRKR Marker Therapeutics, Inc.

Fundamentals / CIK 0001094038 / USD

Marker Therapeutics, Inc. reported $3.55M in revenue and a net loss of $8.55M for the fiscal year ended December 31, 2025 (down 46.2% year over year), with a -264.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MRKR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$22.12M$11.06M$0-$138.9MFY 2016 Net Income: -$2.46M2016FY 2017 Revenue: $183KFY 2017 Net Income: -$10.98M2017FY 2018 Revenue: $206KFY 2018 Net Income: -$148.0M2018FY 2019 Revenue: $213KFY 2019 Net Income: -$21.43M2019FY 2020 Revenue: $500KFY 2020 Net Income: -$28.71M2020FY 2021 Revenue: $0FY 2021 Net Income: -$41.88M2021FY 2022 Revenue: $3.51MFY 2022 Net Income: -$29.93M2022FY 2023 Revenue: $3.31MFY 2023 Net Income: -$8.24M2023FY 2024 Revenue: $6.59MFY 2024 Net Income: -$10.73M2024FY 2025 Revenue: $3.55MFY 2025 Net Income: -$12.16M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $3.55M $6.59M $3.31M $3.51M $0 $500K $213K $206K $183K --
Research & Development $11.80M $13.47M $10.42M $11.97M $27.79M $18.88M $12.76M $7.95M $5.25M $3.80M
Total Operating Expenses $16.44M $17.71M $17.89M $23.30M $40.72M $29.35M $22.74M $148.4M $11.66M $8.49M
Operating Income -$12.89M -$11.12M -$14.58M -$19.79M -$39.48M -$28.89M -$22.53M -$148.2M -$11.48M -$8.49M
EBITDA -- -- -- -$17.00M -$37.33M -$28.40M -$22.42M -- -- --
Interest Income $594K $437K $539K $248K $5.7K $149K $1.08M $254K $0 --
Interest Expense -- -- -- -- -- -- -- -- -- $0
Income Before Tax -$12.18M -$10.68M -$14.04M -$19.78M -- -- -- -- -- --
Income Tax Expense -$15K $50K $3.7K -- -- -- -- $0 $0 $0
Net Income -$12.16M -$10.73M -$8.24M -$29.93M -$41.88M -$28.71M -$21.43M -$148.0M -$10.98M -$2.46M
Basic EPS -$0.79 -$1.19 -$0.94 -$3.58 -$5.47 -$6.10 -$4.70 -$77.50 -$11.60 -$3.60
Diluted EPS -$0.79 -$1.19 -$0.94 -$3.58 -$5.47 -$6.10 -$4.70 -$77.50 -$11.60 -$7.20
Basic Shares Outstanding 15.3M 9.0M 8.8M 8.4M 7.7M 4.7M 4.6M 1.9M 945.3K 689.0K
Diluted Shares Outstanding 15.3M 9.0M 8.8M 8.4M 7.7M 4.7M 4.6M 1.9M 945.3K 742.1K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- $752K $1.10M $1.23M $861K $349K $2.25M
Research & Development $2.17M $1.48M $2.84M $2.14M $2.35M $4.18M $3.14M $5.09M
Total Operating Expenses $3.23M $2.62M $4.07M $2.99M $3.37M $5.12M $4.96M $6.11M
Operating Income -$3.23M -$2.62M -$4.07M $559K -$3.37M -$5.12M -$4.96M -$3.86M
Interest Income $92K $113K $133K $166K $138K $128K $162K $74K
Net Income -$1.84M -$1.83M -$3.18M -$1.70M -$2.00M -$4.02M -$4.45M -$3.84M
Basic EPS -$0.10 -$0.09 -$0.16 -- -$0.12 -$0.29 -$0.40 --
Diluted EPS -$0.10 -$0.09 -$0.16 -- -$0.12 -$0.29 -$0.40 --
Basic Shares Outstanding 19.3M 19.3M 19.3M -- 16.8M 14.0M 11.1M --
Diluted Shares Outstanding 19.3M 19.3M 19.3M -- 16.8M 14.0M 11.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $16.07M $19.19M $15.11M $11.78M $42.35M $21.35M $43.90M $61.75M $5.13M $7.85M
Cash & Short-Term Investments $16.07M $19.19M $15.11M $11.78M $42.35M $21.35M $43.90M $61.75M $5.13M $7.85M
Other Current Assets -- $2.0K -- -- -- -- -- -- -- --
Total Current Assets $19.07M $22.02M $17.13M $16.62M $45.98M $24.41M $45.49M $62.00M $5.18M $7.92M
Property, Plant & Equipment, Net -- -- -- $12.32M $12.32M $10.36M $418K $148K $0 --
Total Non-Current Assets $0 $0 $0 $17.80M $22.15M $21.20M $873K $148K $0 $0
Total Assets $19.07M $22.02M $17.13M $34.42M $68.14M $45.61M $46.36M $62.14M $5.18M $7.92M
Accounts Payable $794K $1.07M $961K $1.10M $5.14M $2.94M $993K $1.62M $1.01M $680K
Deferred Revenue (Current) $975K -- -- $0 $1.15M -- -- -- -- --
Other Current Liabilities -- $1.71M $1.33M -- -- -- -- -- $0 $492K
Total Current Liabilities $2.27M $3.46M $3.07M $7.78M $12.90M $6.40M $1.99M $2.80M $1.52M $1.74M
Total Non-Current Liabilities $0 $0 $0 $7.04M $11.25M $11.87M $280K $0 $0 $0
Total Liabilities $2.27M $3.46M $3.07M $14.82M $24.15M $18.27M $2.27M $2.80M $1.52M $1.74M
Total Debt (incl. Leases) -- -- -- $7.62M $11.90M $12.26M $484K -- -- --
Common Stock $17K $11K $8.9K $8.4K $8.3K $51K $46K $45K $11K $8.4K
Retained Earnings -$459.2M -$447.0M -$436.3M -$428.0M -$398.1M -$356.2M -$327.5M -$306.1M -$157.4M -$145.8M
Total Stockholders' Equity $16.80M $18.56M $14.05M $19.60M $43.99M $27.34M $44.09M $59.34M $3.66M $6.18M
Total Equity $16.80M $18.56M $14.05M $19.60M $43.99M $27.34M $44.09M $59.34M $3.66M $6.18M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $9.04M $11.33M $14.92M $16.07M $17.59M $10.46M $13.69M $19.19M
Cash & Short-Term Investments $9.04M $11.33M $14.92M $16.07M $17.59M $10.46M $13.69M $19.19M
Other Current Assets -- $7.2K $13K -- -- -- -- $2.0K
Total Current Assets $12.50M $14.59M $17.43M $19.07M $21.73M $14.77M $16.99M $22.02M
Total Non-Current Assets $0 $0 $0 $0 $0 $0 $0 $0
Total Assets $12.50M $14.59M $17.43M $19.07M $21.73M $14.77M $16.99M $22.02M
Accounts Payable $867K $585K $1.50M $794K $951K $1.72M $1.30M $1.07M
Deferred Revenue (Current) -- -- -- $975K $1.35M $1.35M -- --
Other Current Liabilities $244K $805K $1.00M -- $328K $657K $411K $1.71M
Total Current Liabilities $2.00M $2.42M $3.64M $2.27M $3.35M $4.28M $2.50M $3.46M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $2.00M $2.42M $3.64M $2.27M $3.35M $4.28M $2.50M $3.46M
Common Stock $17K $17K $17K $17K $17K $11K $11K $11K
Retained Earnings -$466.0M -$464.2M -$462.4M -$459.2M -$457.5M -$455.5M -$451.5M -$447.0M
Total Stockholders' Equity $10.50M $12.17M $13.80M $16.80M $18.39M $10.49M $14.49M $18.56M
Total Equity $10.50M $12.17M $13.80M $16.80M $18.39M $10.49M $14.49M $18.56M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$12.16M -$10.73M -$8.24M -$29.93M -$41.88M -$28.71M -$21.43M -$148.0M -$10.98M -$2.46M
Depreciation & Amortization -- -- -- $2.79M $2.15M $486K $105K -- -- --
Stock-Based Compensation $538K $246K $858K $3.30M $5.96M $5.23M $5.36M $16.35M $2.74M $1.56M
Operating Cash Flow -$12.01M -$10.91M -$16.44M -$26.97M -$27.28M -$20.03M -$18.28M -$14.48M -$8.44M -$6.51M
Capital Expenditure -- -- -- -- -- -- -$375K -$148K $0 --
Free Cash Flow -- -- -- -- -- -- -$18.66M -$14.63M -$8.44M --
Investing Cash Flow -- -- $18.66M -$4.95M -$3.13M -$9.25M -$375K -$148K $0 --
Common Stock Issued $9.86M $14.93M $1.01M $202K $52.55M $6.19M $0 -- -- --
Share Repurchases -- -- -- -- -- -- -- -$72K -$310K $0
Financing Cash Flow $9.86M $14.99M $1.11M $202K $52.56M $6.74M $816K $71.25M $5.72M $7.78M
Net Change in Cash -$2.15M $4.08M $3.33M $11.80M $43.50M -$22.55M -$17.84M $56.62M -- --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.84M -$1.83M -$3.18M -$1.70M -$2.00M -$4.02M -$4.45M -$3.84M
Stock-Based Compensation $182K $196K $178K $111K $33K $14K $379K $51K
Operating Cash Flow -$2.49M -$3.72M -$1.40M -$1.90M -$2.74M -$1.88M -$5.50M -$4.70M
Financing Cash Flow -- -- -- $0 $9.86M $100 $505 $14.90M
Net Change in Cash -$2.49M -$3.72M -$1.40M -$1.90M $7.13M -$1.88M -$5.50M $10.19M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -363.5% -168.7% -440.4% -563.3% -- -5777.2% -10567.3% -71930.1% -6271.1% --
Net Profit Margin -343.0% -162.8% -248.8% -851.9% -- -5741.2% -10050.9% -71826.3% -5999.1% --
Return on Equity (ROE) -72.4% -57.8% -58.6% -152.7% -95.2% -105.0% -48.6% -249.3% -300.2% -39.7%
Return on Assets (ROA) -63.8% -48.7% -48.1% -87.0% -61.5% -62.9% -46.2% -238.1% -212.0% -31.0%
Current Ratio 8.39x 6.36x 5.57x 2.14x 3.56x 3.81x 22.83x 22.11x 3.40x 4.56x
Quick Ratio 7.07x 5.54x 4.91x 1.51x 3.28x 3.34x 22.03x 22.02x 3.37x 4.52x
Debt to Equity -- -- -- 0.39x 0.27x 0.45x 0.01x -- -- --
Revenue Growth (YoY) -46.2% +99.1% -5.8% -- -100.0% +134.5% +3.5% +12.5% -- --
5Y Revenue / Share Growth +117.9% +1469.4% +248.4% +117.3% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -304.0% -363.5% -368.7% -303.3% -237.5% -168.7%
Net Profit Margin -- -- -275.9% -343.0% -304.5% -271.1% -224.4% -162.8%
Return on Equity (ROE) -81.4% -71.6% -79.0% -72.4% -77.8% -139.2% -88.2% -57.8%
Return on Assets (ROA) -68.4% -59.7% -62.5% -63.8% -65.8% -98.9% -75.2% -48.7%
Current Ratio 6.26x 6.03x 4.79x 8.39x 6.50x 3.45x 6.79x 6.36x
Quick Ratio 4.53x 4.68x 4.10x 7.07x 5.26x 2.45x 5.47x 5.54x
Revenue Growth (YoY) -- -- +115.3% -51.0% -36.0% -26.3% -71.9% +113.1%
Operating Cash Flow Growth (YoY) -- -- -- -- -328.5% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001094038) · from December 31, 2000 Data through September 30, 2026 · synced Nov 21, 2026, 05:04 UTC · Open in terminal